Tnf Pharmaceuticals Inc (TNFA)

Apr 30, 2025

A new trading data show TNF Pharmaceuticals Inc (TNFA) is showing positive returns. - Sete News

Apr 30, 2025

Apr 28, 2025

TNF Pharmaceuticals Inc Inc. (TNFA) Price Performance: A Guide to Financial Ratios - investchronicle.com

Apr 28, 2025

Apr 28, 2025

Is TNF Pharmaceuticals Inc (TNFA) worth investing in despite its overvalued state? - uspostnews.com

Apr 28, 2025

Apr 26, 2025

Gaining Ground: TNF Pharmaceuticals Inc (TNFA) Closes Lower at 0.25, Down -9.00 - DWinneX

Apr 26, 2025

Apr 26, 2025

Comparing TNF Pharmaceuticals (NASDAQ:TNFA) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Apr 26, 2025

Apr 25, 2025

TNF Pharmaceuticals Inc (NASDAQ:TNFA) Is Looking Good Over The Long Term, Dropped Nearly -46.01% Over A Month. – Marketing Sentinel - Marketing Sentinel

Apr 25, 2025

Apr 24, 2025

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ - GlobeNewswire

Apr 24, 2025

Apr 24, 2025

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.

Apr 24, 2025

Apr 23, 2025

TNF Pharmaceuticals Inc (TNFA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News

Apr 23, 2025

Apr 23, 2025

TNF Pharmaceuticals To Use AI To Recruit Patients For Drug Development: Retail Stays Bearish - MSN

Apr 23, 2025

Apr 23, 2025

TNF and Renova Health use AI to identify patients for GLP-1 treatments - Yahoo Finance

Apr 23, 2025

Apr 22, 2025

TNF Pharmaceuticals To Use AI To Recruit Patients For Drug Development: Retail Stays Bearish By Stocktwits - Investing.com India

Apr 22, 2025

Apr 22, 2025

TNF Pharmaceuticals uses AI to refine patient selection for trials By Investing.com - Investing.com South Africa

Apr 22, 2025

Apr 22, 2025

TNF Pharmaceuticals uses AI to refine patient selection for trials - Investing.com

Apr 22, 2025

Apr 22, 2025

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development - Business Wire

Apr 22, 2025

Apr 21, 2025

Clearmind Medicine Inc Inc. (CMND) Price Performance and Its Relation to the Tech Industry - investchronicle.com

Apr 21, 2025

Apr 21, 2025

TNF Pharmaceuticals Inc Inc. (TNFA) Price Performance Over the Years: A Comparative Study - investchronicle.com

Apr 21, 2025

Apr 21, 2025

Market Recap Check: Sangamo Therapeutics Inc (SGMO)’s Positive Finish at 0.71, Up/Down 2.96 - DWinneX

Apr 21, 2025

Apr 18, 2025

Gaining Ground: TNF Pharmaceuticals Inc (TNFA) Closes Lower at 0.18, Down -25.44 - DWinneX

Apr 18, 2025

Apr 18, 2025

Pre-market Movers: OPTN, WINT, AKBA, GCTK... - RTTNews

Apr 18, 2025

Apr 17, 2025

Pre-market Movers: CHRO, QURE, FOTA, LLY... - RTTNews

Apr 17, 2025

Apr 17, 2025

Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 17, 2025

Apr 16, 2025

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society’s Spring Meeting 2025 - The Joplin Globe

Apr 16, 2025

Apr 15, 2025

Corebridge Financial Inc. Trims Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Apr 15, 2025

Apr 11, 2025

TNF Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Apr 11, 2025

Apr 08, 2025

TNF Pharmaceuticals Inc: Navigating Market Fluctuations with a 0.75M Market Cap - investchronicle.com

Apr 08, 2025

Apr 08, 2025

TNFA stock touches 52-week low at $0.32 amid market challenges - Investing.com Canada

Apr 08, 2025

Apr 07, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 07, 2025

Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 01, 2025

Mar 29, 2025

Now Is A Good Time To Buy TNF Pharmaceuticals Inc (NASDAQ: TNFA) - Marketing Sentinel

Mar 29, 2025

Mar 27, 2025

A Key Driver Transforming the TNF Alpha Inhibitors Market in 2025: The Prevalence Of Inflammatory Diseases ... - WhaTech

Mar 27, 2025

Mar 26, 2025

Contrasting Myriad Genetics (NASDAQ:MYGN) & TNF Pharmaceuticals (NASDAQ:TNFA) - Defense World

Mar 26, 2025

Mar 21, 2025

TNF Pharmaceuticals faces Nasdaq delisting over price - Investing.com

Mar 21, 2025

Mar 21, 2025

TNF Pharmaceuticals faces Nasdaq delisting over price By Investing.com - Investing.com India

Mar 21, 2025

Mar 20, 2025

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent - Business Wire

Mar 20, 2025

Mar 20, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Mar 20, 2025

Mar 19, 2025

Sarcopenia Market Expected to Experience Major Growth by 2034, - openPR.com

Mar 19, 2025

Mar 18, 2025

TNF Pharmaceuticals presents isomyosamine data - Yahoo Finance

Mar 18, 2025

Mar 17, 2025

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia - Joplin Globe

Mar 17, 2025

Mar 13, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 13, 2025

Mar 10, 2025

TNF Pharmaceuticals Discusses Isomyosamine Progress in Call - TipRanks

Mar 10, 2025

Mar 05, 2025

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025 - BioSpace

Mar 05, 2025

Mar 04, 2025

Raythera describes new TNF-α modulators - BioWorld Online

Mar 04, 2025

Mar 03, 2025

RILY’s current quarter earnings: What analysts forecast? - US Post News

Mar 03, 2025

Mar 03, 2025

LGVN To Complete ELPIS II Enrollment By Q2, Time To Keep An Eye On NXGL, What's The Buzz At ACON? - RTTNews

Mar 03, 2025

Feb 26, 2025

Are T1 Energy Inc (FREY) shares a good deal now? - US Post News

Feb 26, 2025

Feb 26, 2025

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor - BioSpace

Feb 26, 2025

Feb 25, 2025

Can This First-Ever Oral TNF Inhibitor Disrupt a $40 Billion Market? Phase 2b Trial Begins - StockTitan

Feb 25, 2025